Identification of N-desmethylsibutramine as a new ingredient in Chinese herbal dietary supplements;Identyfikacja N-desmetylosibutraminy w ziołowych suplementach diety produkcji Chińskiej

Problems of Forensic Sciences

Volumn 70, Issue , 2007, Pages 225-235

  Błachut, Dariusz ^a,e   Siwińska Ziółkowska, Agnieszka ^b   Szukalski, Bogdan ^c   Wojtasiewicz, Krystyna ^d   Czarnocki, Zbigniew ^d   Kobyłecka, Agnieszka ^b   Bykas Strȩkowska, Marta ^a  

^a Agencja Bezpieczenstwa Wewnetrznego Warszawa   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^d UNIVERSITY OF WARSAW   (Poland)

^e Biuro Bada Kryminalistycznych ABW   (Poland)

Author keywords

LiDA; Meizitang; N desmethylsibutramine; Sibutramine

Indexed keywords

HERBACEOUS AGENT; NORSIBUTRAMINE; UNCLASSIFIED DRUG;

CARBON NUCLEAR MAGNETIC RESONANCE; CHINESE MEDICINE; COLUMN CHROMATOGRAPHY; CONFERENCE PAPER; DIET SUPPLEMENTATION; DRUG IDENTIFICATION; INFRARED SPECTROSCOPY;

EID: 39449131884     PISSN: 12307483     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Błachut D., Siwińska-Ziółkowska A., Kobyłecka A. [i in.], Analysing the composition of Chinese "herbal" slimming aids, Problems of Forensic Sciences 2006, 66, 199-211.
2. Brooks P. M., Lowenthal R. M., Chinese herbal arthritis cure and agranulocytosis, The Medical Journal of Australia 1977, 2, 860.
3. Cairns T, Siegmund E. G., Rader B. R., Identification of prescription drugs in adulterated Chinese herbal medicines, Pharmaceutical Research 1987, 4, 126-129.
4. Chan H., Yeh Y. Y., Billmeier G. J. [et al.], Lead poisoning from ingestion of Chinese herbal medicine, Clinical Toxicology 1977, 10, 237.
5. Fang Q. K., Senanayake C. H., Han Z. [et al.], First preparation of enantiomerically pure sibutramine and its major metabolite, and determination of their absolute configuration by single crystal X-ray analysis, Tetrahedron-Asymmetry, 1999, 10, 4477-4480.
6. Frazer D. B., Chinese herbal medicines - manufacturing flaws and misuse, Forensic Science Review 1998, 10, 68-80.
7. Gertner E, Marshall P. S., Filandrinos D. [et al.], Complication resulting from the use of Chinese herbal medications containing undeclared prescription drugs, Arthritis and Rheumatism 1995, 38, 614-617.
8. Han Z., Krishnamurthy D., Pflum D. [et al.], First practical synthesis of enantiomerically pure (R)- and (S)-desmethylsibutramine (DMS) and unambiguous determination of their absolute configuration by single-crystal X-ray analysis, Tetrahedron-Asymmetry 2002, 13, 107-109.
9. Jeffery J. E., Kerrigan F., Miller T. K., [et al.], Synthesis of sibutramine, a novel cyclobutylalkylamine useful in the treatment of obesity, and its major human metabolites, Journal of the Chemical Society Perkin Transactions 1996, 1, 2583-2589.
10. Kang-Yum E., Oransky S. H., Chinese patent medicine as a potential source of mercury poisoning, Veterinary and Human Toxicology 1992, 34, 235.
11. Myerson G. E., Myerson A. S., Miller S. B. [et al.], "Herbal medicine" mail order syndrome - A cause of hypercortisonism, Arthritis and Rheumatism 1982, supl. 4, S87.
12. Offerhause L., Duke M. N. G., Smits H. M., "Herbal" medicines and rheumatoid arthritis, British Medical Journal 1979, 2, 668.
13. Ries C. A., Sahud M. A., Agranulocytosis caused by Chinese herbal medicines; danger of medications containing aminopyrine and phenylbutazone, Journal of the American Medical Association 1975, 231, 352.
14. Schaumburg H. H., Berger A., Alopecia and sensory polyneuropathy from thallium in a Chinese herbal medication, Journal of the American Medical Association 1992, 340, 3430.
15. Szukalski B., Błachut D., Siwińska-Ziółkowska A. [i in.], Fałszowanie środków leczniczych: sibutramina, Problemy Kryminalistyki 2007, 257, 13-22.
16. Tay C. H., Seah C. S., Arsenic poisoning from ant-asthmatic herbal preparations, Medical Journal of Australia 2, 424.
17. Wróbel J. T., Preparatyka organiczna, PWN, Warszawa 1976.